U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07071766) titled 'Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment' on July 08.
Brief Summary: Drug overdose is a leading cause of death among postpartum women and opioid-related mortality is 4 times higher in the postpartum period when compared to the third trimester of pregnancy. Medications for opioid use disorder (MOUD; e.g., methadone or buprenorphine) are the recommended standard of care for perinatal women with OUD. Studies indicate that 50-60% of perinatal women with OUD initiate medications during pregnancy; however, over half will prematurely discontinue treatment within the first six months of childbirth due to ...